DR. HÖNLE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.9 EUR | 0.00% |
|
-0.50% | +13.71% |
| Feb. 26 | Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
| Jan. 25 | Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Evolution of the average Target Price on Dr. Hönle AG
Price target over the last 5 years
History of analyst recommendation changes
42716b0998b50e34559cf1b47.OIKhlI0gdEO73xQ4JOIb07CdfzDXOTsxvNh2-mzzzdg.Z7fo4ORKR3TjukF-FrQrnd-sTAOxAV1ExapbtyiilO5i8tbwzxUQAuyAfw~0decec11f2b154eead9f3304c74fc7da
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.9
EUR
Average target price
29.15
EUR
Spread / Average Target
+46.48%
High Price Target
29.3
EUR
Spread / Highest target
+47.24%
Low Price Target
29
EUR
Spread / Lowest Target
+45.73%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Dr. Hönle AG
| HAUCK & AUFHÄUSER | Tim Wunderlich |
| WARBURG RESEARCH | Malte Schaumann |
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- HNL Stock
- Consensus Dr. Hönle AG
